Follow
Peter Gibbs
Peter Gibbs
Verified email at wehi.edu.au
Title
Cited by
Cited by
Year
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
46642014
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ...
The Lancet 381 (9863), 303-312, 2013
30342013
Detection and localization of surgically resectable cancers with a multi-analyte blood test
JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ...
Science 359 (6378), 926-930, 2018
23252018
Pembrolizumab in microsatellite-instability–high advanced colorectal cancer
T André, KK Shiu, TW Kim, BV Jensen, LH Jensen, C Punt, D Smith, ...
New England Journal of Medicine 383 (23), 2207-2218, 2020
18602020
Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ...
The Journal of pathology 232 (2), 199-209, 2014
14692014
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
J Tie, Y Wang, C Tomasetti, L Li, S Springer, I Kinde, N Silliman, M Tacey, ...
Science translational medicine 8 (346), 346ra92-346ra92, 2016
13592016
Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ...
Journal of translational medicine 10, 1-10, 2012
9462012
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
B Tran, S Kopetz, J Tie, P Gibbs, ZQ Jiang, CH Lieu, A Agarwal, DM Maru, ...
Cancer 117 (20), 4623-4632, 2011
8222011
Effect of aspirin on all-cause mortality in the healthy elderly
JJ McNeil, MR Nelson, RL Woods, JE Lockery, R Wolfe, CM Reid, ...
New England Journal of Medicine 379 (16), 1519-1528, 2018
7792018
Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer
S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ...
Journal of clinical oncology 33 (34), 4032, 2015
7252015
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J Tie, I Kinde, Y Wang, HL Wong, J Roebert, M Christie, M Tacey, R Wong, ...
Annals of Oncology 26 (8), 1715-1722, 2015
6262015
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ...
Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017
5262017
Effect of aspirin on disability-free survival in the healthy elderly
JJ McNeil, RL Woods, MR Nelson, CM Reid, B Kirpach, R Wolfe, E Storey, ...
New England Journal of Medicine 379 (16), 1499-1508, 2018
4992018
Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer
RN Jorissen, P Gibbs, M Christie, S Prakash, L Lipton, J Desai, D Kerr, ...
Clinical Cancer Research 15 (24), 7642-7651, 2009
4732009
Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer
J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee, R Wong, ...
JAMA oncology 5 (12), 1710-1717, 2019
4722019
Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution
SM Dewhurst, N McGranahan, RA Burrell, AJ Rowan, E Grönroos, ...
Cancer discovery 4 (2), 175-185, 2014
4212014
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang, S Kosmider, R Wong, ...
New England Journal of Medicine 386 (24), 2261-2272, 2022
4092022
SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation …
GA Van Hazel, V Heinemann, NK Sharma, M Peeters
Journal of clinical oncology.-New York 34 (15), 1723-1731, 2016
3922016
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer
NI Fleming, RN Jorissen, D Mouradov, M Christie, A Sakthianandeswaren, ...
Cancer research 73 (2), 725-735, 2013
3752013
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
3672017
The system can't perform the operation now. Try again later.
Articles 1–20